NovoCure Ltd (NVCR)
14.77
+0.58
(+4.09%)
USD |
NASDAQ |
May 03, 16:00
14.77
0.00 (0.00%)
After-Hours: 20:00
NovoCure Cash from Financing (Quarterly): 1.91M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.91M |
September 30, 2023 | 1.171M |
June 30, 2023 | 7.502M |
March 31, 2023 | 5.204M |
December 31, 2022 | 3.41M |
September 30, 2022 | 4.204M |
June 30, 2022 | 4.736M |
March 31, 2022 | 3.141M |
December 31, 2021 | 3.652M |
September 30, 2021 | 3.036M |
June 30, 2021 | 11.06M |
March 31, 2021 | 7.955M |
December 31, 2020 | 570.85M |
September 30, 2020 | -140.49M |
June 30, 2020 | 5.345M |
March 31, 2020 | 4.503M |
December 31, 2019 | 8.586M |
September 30, 2019 | 15.47M |
Date | Value |
---|---|
June 30, 2019 | 20.66M |
March 31, 2019 | 16.97M |
December 31, 2018 | 2.565M |
September 30, 2018 | 3.902M |
June 30, 2018 | 11.19M |
March 31, 2018 | 51.71M |
December 31, 2017 | 1.329M |
September 30, 2017 | 1.713M |
June 30, 2017 | 2.067M |
March 31, 2017 | 0.059M |
December 31, 2016 | 1.328M |
September 30, 2016 | 72.85M |
June 30, 2016 | 0.902M |
March 31, 2016 | 0.041M |
December 31, 2015 | 161.26M |
September 30, 2015 | -1.443M |
June 30, 2015 | 93.39M |
March 31, 2015 | 23.79M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-140.49M
Minimum
Sep 2020
570.85M
Maximum
Dec 2020
28.52M
Average
4.736M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
AtriCure Inc | -7.862M |
NeuroMetrix Inc | 1.624M |
Repligen Corp | -8.974M |
Teleflex Inc | -237.50M |
Perspective Therapeutics Inc | 0.352M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -14.56M |
Cash from Investing (Quarterly) | 98.50M |
Free Cash Flow | -100.43M |
Free Cash Flow Per Share (Quarterly) | -0.20 |
Free Cash Flow to Equity (Quarterly) | -22.22M |
Free Cash Flow to Firm (Quarterly) | -21.38M |
Free Cash Flow Yield | -6.39% |